The implementation of a personnel training and assessment program for new standards in the US Pharmacopeia general Chapter 〈797〉 pharmaceutical compounding of sterile preparations

Hospital Pharmacy

Volumn 41, Issue 1, 2006, Pages 43-48

  Trapskin, Philip J ^a   Reagan, Rebecca ^b   Hite, Kimberley ^b   Armitstead, John A ^b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Assessment; Compounding; Evaluation; Sterile preparations, USP chapter 797 ; Training

Indexed keywords

ARTICLE; DRUG FORMULATION; EVALUATION; INSTRUMENT STERILIZATION; ONLINE SYSTEM; PERSONNEL MANAGEMENT; PHARMACY; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; RISK ASSESSMENT; SKILL; STANDARD; STUDENT T TEST; TEACHING; TRAINING;

EID: 31544453058     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4101-43     Document Type: Article

References (12)

1. Meisler JM, Skolaut MW. Extemporaneous sterile compounding of intravenous additives. Am J Hosp Pharm. 1966;23(10):557-563.
2. Pulliam CC, Upton JH. A pharmacy coordinated intravenous admixture and administration service. Am J Hosp Pharm. 1971;28(2):92-101.
3. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm. 1975;32(3):261-270.
4. Morris BG, Avis KE, Bowles GC. Quality-control plan for intravenous admixture programs. II: validation of operator technique. Am J Hosp Pharm. 1980;37(5):668-672.
5. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm. 1993;50(11):2386-2398.
6. American Society of Health System Pharmacists. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm. 2000;57(12):1150-1169.
7. The United States Pharmacopeia, 28th revision and The National Formulary, 23rd ed. United States Pharmacopeial Convention; Rockville, MD: 2005:2461-2477.
8. Morris AM, Schneider PJ, Pedersen CA, Mirtallo JM. National survey of quality assurance activities for pharmacy-compounded sterile preparations. Am J Health Syst Pharm. 2003;60(24):2567-2576.
9. Kopcha RG. Lack of evidence for ASHP's sterile-products guidelines. Am J Health Syst Pharm. 2004;61(14):1445-1446.
10. Dirks I, Smith FM, Furtado D, White SJ, Godwin HN. Method for testing aseptic technique of intravenous admixture personnel. Am J Hosp Pharm. 1982;39(3):457-459.
11. Trissel LA, Ogundele AB, Ingram DS, Saenz CA, Gentempo JA. Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding. Am J Health Syst Pharm. 2003;60(18):1853-1855.
12. Trissel LA, Gentempo JA, Anderson RW, Lajeunesse JD. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding. Am J Health Syst Pharm. 2005;62(3):285-288.